NSCLC Patients May Benefit From Single Dose of SBRT

NSCLC Patients May Benefit From Single Dose of SBRT

User Photo
roswellpark

3 years
686 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Anurag Singh, MD, shares new research indicating that non-small cell lung cancer (NSCLC) patients may benefit from a single dose of stereotactic body radiation therapy (SBRT) as much as they would from three separate SBRT treatments. Read more: https://goo.gl/3I4mxf
Up Next Autoplay